UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 8,505	$ 12,128	$ 11,843
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	660	610	619
Amortization	2,113	2,223	2,528
Provision for (recovery of) losses on accounts receivable	4	0	(10)
Loss on disposal of assets	17	5	1
Deferred income taxes	(658)	(484)	(901)
Stock-based compensation expense	129	92	87
(Increase) decrease in accounts receivable	(242)	295	137
(Increase) decrease in other receivables	2	897	(91)
(Increase) decrease in inventories	(467)	(360)	422
(Increase) decrease in prepaid expenses and other current assets	24	23	28
Increase (decrease) in accounts payable	9	286	(265)
Increase (decrease) in accrued expenses	1,027	(1,187)	(597)
Increase (decrease) in Long-term repatriation tax payable	5,785
Net cash provided by operating activities	16,908	14,528	13,801
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures for property and equipment	(1,597)	(3,293)	(176)
Capital expenditures for intangible assets		(9)	(70)
Net cash provided by (used in) investing activities	(1,597)	(3,302)	(246)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	302	376	343
Common stock purchased and retired		(2,850)	(683)
Payment of taxes for exchange of stock options			(42)
Tax benefit attributable to exercise of stock options		50	114
Repayments of notes payable			(4,777)
Dividends paid	(2,955)	(3,916)	(3,846)
Net cash provided by (used in) financing activities	(2,653)	(6,340)	(8,891)
Effect of exchange rate changes on cash	921	(1,868)	(660)
NET INCREASE IN CASH AND CASH EQUIVALENTS	13,579	3,018	4,004
CASH AT BEGINNING OF YEAR	26,296	23,278	19,274
CASH AT END OF YEAR	39,875	26,296	23,278
Cash paid during the year for income taxes	$ 5,151	$ 4,846	5,341
Cash paid during the year for interest			$ 65